株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

骨粗鬆症治療薬の世界市場

Osteoporosis Therapeutics

発行 Global Industry Analysts, Inc. 商品コード 912424
出版日 ページ情報 英文 158 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.71円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
骨粗鬆症治療薬の世界市場 Osteoporosis Therapeutics
出版日: 2019年10月01日 ページ情報: 英文 158 Pages
概要

当レポートでは、世界における骨粗鬆症治療薬市場の概要、動向・発展への影響因子の分析、競合企業と市場シェア、世界および地域・主要国別の市場規模の推移と予測、主要企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界市場における企業シェア
    • 世界の骨粗鬆症治療薬市場における企業シェアのシナリオ
  • 主要企業
  • 市場の動向と発展因子
  • 世界市場の見通し

第3章 市場分析

  • 地域別市場の分析
    • 米国
    • カナダ
    • 日本
    • 中国
    • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他欧州
    • アジア太平洋地域
    • オーストラリア
    • インド
    • 韓国
    • その他アジア太平洋地域
    • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
    • 中東
    • イラン
    • イスラエル
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東
    • アフリカ

第4章 競合企業

  • ALLERGAN PLC
  • AMGEN
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • MERCK KGAA
  • NOVARTIS INTERNATIONAL AG
  • NOVO NORDISK A/S
  • PFIZER
  • TEVA PHARMACEUTICAL INDUSTRIES

第5章 調査資料

目次
Product Code: MCP-1229

Osteoporosis Therapeutics market worldwide is projected to grow by US$3.7 Billion, driven by a compounded growth of 3.8%. Bisphosphonates, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$6.7 Billion by the year 2025, Bisphosphonates will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$133.8 Million to the region's size and clout in the next 5 to 6 years. Over US$107.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Bisphosphonates will reach a market size of US$371.4 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6% over the next couple of years and add approximately US$1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Allergan PLC; Allergan PLC; Amgen, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Merck KGaA; Novartis International AG; Novo Nordisk A/S; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Osteoporosis Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Osteoporosis Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Osteoporosis Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Osteoporosis Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Bisphosphonates (Drug Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Bisphosphonates (Drug Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Bisphosphonates (Drug Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Parathyroid Hormone Therapy (Drug Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Parathyroid Hormone Therapy (Drug Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Parathyroid Hormone Therapy (Drug Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Calcitonin (Drug Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Calcitonin (Drug Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Calcitonin (Drug Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Selective Estrogen Inhibitors Modulator (SERM) (Drug Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Selective Estrogen Inhibitors Modulator (SERM) (Drug Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Selective Estrogen Inhibitors Modulator (SERM) (Drug Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Rank Ligand Inhibitors (Drug Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Rank Ligand Inhibitors (Drug Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Rank Ligand Inhibitors (Drug Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Osteoporosis Therapeutics Market Share (in %) by Company: 2019 & 2025
    • TABLE 19: United States Osteoporosis Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025
    • TABLE 20: Osteoporosis Therapeutics Market in the United States by Drug Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 21: United States Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 22: Canadian Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025
    • TABLE 23: Canadian Osteoporosis Therapeutics Historic Market Review by Drug Type in US$ Million: 2009-2017
    • TABLE 24: Osteoporosis Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025
  • JAPAN
    • TABLE 25: Japanese Market for Osteoporosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 26: Osteoporosis Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017
    • TABLE 27: Japanese Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 28: Chinese Osteoporosis Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 29: Osteoporosis Therapeutics Historic Market Analysis in China in US$ Million by Drug Type: 2009-2017
    • TABLE 30: Chinese Osteoporosis Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Osteoporosis Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 31: European Osteoporosis Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 32: Osteoporosis Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 33: European Osteoporosis Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 34: European Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025
    • TABLE 35: Osteoporosis Therapeutics Market in Europe in US$ Million by Drug Type: A Historic Review for the Period 2009-2017
    • TABLE 36: European Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 37: Osteoporosis Therapeutics Market in France by Drug Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 38: French Osteoporosis Therapeutics Historic Market Scenario in US$ Million by Drug Type: 2009-2017
    • TABLE 39: French Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 40: Osteoporosis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 41: German Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017
    • TABLE 42: German Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 43: Italian Osteoporosis Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 44: Osteoporosis Therapeutics Historic Market Analysis in Italy in US$ Million by Drug Type: 2009-2017
    • TABLE 45: Italian Osteoporosis Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 46: United Kingdom Market for Osteoporosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 47: Osteoporosis Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017
    • TABLE 48: United Kingdom Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 49: Spanish Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025
    • TABLE 50: Spanish Osteoporosis Therapeutics Historic Market Review by Drug Type in US$ Million: 2009-2017
    • TABLE 51: Osteoporosis Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 52: Russian Osteoporosis Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025
    • TABLE 53: Osteoporosis Therapeutics Market in Russia by Drug Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 54: Russian Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 55: Rest of Europe Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025
    • TABLE 56: Osteoporosis Therapeutics Market in Rest of Europe in US$ Million by Drug Type: A Historic Review for the Period 2009-2017
    • TABLE 57: Rest of Europe Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 58: Asia-Pacific Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 59: Osteoporosis Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 60: Asia-Pacific Osteoporosis Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 61: Osteoporosis Therapeutics Market in Asia-Pacific by Drug Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 62: Asia-Pacific Osteoporosis Therapeutics Historic Market Scenario in US$ Million by Drug Type: 2009-2017
    • TABLE 63: Asia-Pacific Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 64: Osteoporosis Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 65: Australian Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017
    • TABLE 66: Australian Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 67: Indian Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025
    • TABLE 68: Indian Osteoporosis Therapeutics Historic Market Review by Drug Type in US$ Million: 2009-2017
    • TABLE 69: Osteoporosis Therapeutics Market in India: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 70: Osteoporosis Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 71: South Korean Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017
    • TABLE 72: Osteoporosis Therapeutics Market Share Distribution in South Korea by Drug Type: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 73: Rest of Asia-Pacific Market for Osteoporosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 74: Osteoporosis Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017
    • TABLE 75: Rest of Asia-Pacific Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 76: Latin American Osteoporosis Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 77: Osteoporosis Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 78: Latin American Osteoporosis Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 79: Latin American Osteoporosis Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 80: Osteoporosis Therapeutics Historic Market Analysis in Latin America in US$ Million by Drug Type: 2009-2017
    • TABLE 81: Latin American Osteoporosis Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 82: Argentinean Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025
    • TABLE 83: Osteoporosis Therapeutics Market in Argentina in US$ Million by Drug Type: A Historic Review for the Period 2009-2017
    • TABLE 84: Argentinean Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 85: Osteoporosis Therapeutics Market in Brazil by Drug Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 86: Brazilian Osteoporosis Therapeutics Historic Market Scenario in US$ Million by Drug Type: 2009-2017
    • TABLE 87: Brazilian Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 88: Osteoporosis Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 89: Mexican Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017
    • TABLE 90: Mexican Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 91: Rest of Latin America Osteoporosis Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025
    • TABLE 92: Osteoporosis Therapeutics Market in Rest of Latin America by Drug Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 93: Rest of Latin America Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 94: The Middle East Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 95: Osteoporosis Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 96: The Middle East Osteoporosis Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 97: The Middle East Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025
    • TABLE 98: The Middle East Osteoporosis Therapeutics Historic Market by Drug Type in US$ Million: 2009-2017
    • TABLE 99: Osteoporosis Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025
  • IRAN
    • TABLE 100: Iranian Market for Osteoporosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 101: Osteoporosis Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017
    • TABLE 102: Iranian Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 103: Israeli Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025
    • TABLE 104: Osteoporosis Therapeutics Market in Israel in US$ Million by Drug Type: A Historic Review for the Period 2009-2017
    • TABLE 105: Israeli Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 106: Saudi Arabian Osteoporosis Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 107: Osteoporosis Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Type: 2009-2017
    • TABLE 108: Saudi Arabian Osteoporosis Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 109: Osteoporosis Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 110: United Arab Emirates Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017
    • TABLE 111: Osteoporosis Therapeutics Market Share Distribution in United Arab Emirates by Drug Type: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 112: Osteoporosis Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025
    • TABLE 113: Rest of Middle East Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017
    • TABLE 114: Rest of Middle East Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 115: African Osteoporosis Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025
    • TABLE 116: Osteoporosis Therapeutics Market in Africa by Drug Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 117: African Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ALLERGAN PLC
  • AMGEN
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • MERCK KGAA
  • NOVARTIS INTERNATIONAL AG
  • NOVO NORDISK A/S
  • PFIZER
  • TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Back to Top